Search for a research project
Other search option(s)
79 Result(s)
Funded by an IRDiRC member = 
Research projects
BELGIUM
OOST-VLAANDEREN
GENT
Retinitis pigmentosa: genidentificatie en functionele analyse door geavanceerde genomica en zebravis studies
Center for Medical Genetics Gent
FRANCE
AUVERGNE-RHONE-ALPES
LYON
LipidinRetina: Dysregulation of lipid metabolism on photoreceptor function and viability : The role of FATP genes in Drosophila and mice models
ENS - Ecole normale supérieure de Lyon
Laboratoire de Biologie Moléculaire de la Cellule
FRANCE
ILE-DE-FRANCE
PARIS
FRANCE
ILE-DE-FRANCE
PARIS
Preclinical validation of a stem cell-derived Retinal Pigmented Epithelium (RPE) in non-human primates
Institut de la Vision
Centre de Recherches Institut de la Vision - INSERM U 968
FRANCE
ILE-DE-FRANCE
PARIS
Hereditary dystrophies of retina: physiopathologic and clinic research
Institut de la Vision
Recherche Clinique
FRANCE
ILE-DE-FRANCE
PARIS
Hereditary dystrophies of retina: pharmacological research and new therapeutics development (cell and gene therapies)
Institut de la Vision
Recherche Clinique
FRANCE
OCCITANIE
MONTPELLIER
Genetics of autosomal recessive retinitis pigmentosa and of macular dystrophies
Hôpital Saint Eloi - Bâtiment INM
Equipe "Génétique et thérapie des cécités rétiniennes et du nerf optique"
FRANCE
OCCITANIE
MONTPELLIER
Dominant autosomic retinitis pigmentosa: prevalence of known genes and identification of new ones
Hôpital Saint Eloi - Bâtiment INM
Equipe "Génétique et thérapie des cécités rétiniennes et du nerf optique"
FRANCE
PAYS DE LA LOIRE
NANTES
Evaluation of the immune response in Briards dogs RPE65 -/- treated with gene therapy
CHU de Nantes - Hôtel Dieu
Vecteurs viraux et transfert de genes in vivo
GERMANY
Bayern
REGENSBURG
Functional analysis of FAM161A proteine and investigation of FAM161A associated retinal degeneration
Universitätsklinikum Regensburg
Zentrum für Humangenetik Regensburg
GERMANY
Berlin
BERLIN
Stem cell based therapy in a mouse model with rhodopsin associated retinal degeneration
Augenarzt-Praxis in Berlin-Mitte
GERMANY
Berlin
BERLIN
Phenotyping of mouse lines with retinal functional impairment and retinal degeneration
Augenarzt-Praxis in Berlin-Mitte
GERMANY
Hessen
FRANKFURT AM MAIN
OPTOREMODE: Retinitis Pigmentosa diagnosis and therapy: retinal remodeling and optogenetic reactivation of degenerated retina (partner no 2) - DE
Max-Planck-Institut für Hirnforschung
GERMANY
Nordrhein-Westfalen
KÖLN
Functional analysis of FAM161A proteine and investigation of FAM161A associated retinal degeneration
Universitätsklinikum Köln
Zentrum für Augenheilkunde
ITALY
CAMPANIA
NAPOLI
AAVEYE: optimization of AAV-mediated photoreceptor gene transfer for gene therapy of PDE6B and AIPL1 deficiencies (WP1)
TIGEM - Telethon Institute of Genetics and Medicine
Laboratorio di Ricerca
ITALY
EMILIA ROMAGNA
MODENA
Exploring PEDF as therapeutic agent for retinitis pigmentosa
Università degli Studi di Modena e Reggio Emilia
Laboratorio Eye Diseases
ITALY
LIGURIA
GENOVA
Development and application of optoneural prosthetic devices as a therapeutic approach for Retinitis pigmentosa
IRCCS AOU San Martino - IST - DIMI
Dipartimento di Medicina Sperimentale
ITALY
TOSCANA
PISA
How to drive embryonic stem cells toward a retinal fate: role of eye specific transcription factors
Azienda Ospedaliero Universitaria Pisana - Ospedale S. Chiara
Dipartimento di Biologia
ITALY
TOSCANA
PISA
Integrate analysis of the cellular and molecular processes responsible for the elaboration of sensory signals in normal and pathological conditions.
Università degli Studi di Pisa
Dipartimento di Farmacia
NETHERLANDS
Gelderland
NIJMEGEN
Identification of the genetic causes of inherited retinal dystrophies
Radboudumc - Radboud universitair medisch centrum
Afdeling Genetica
NETHERLANDS
Gelderland
NIJMEGEN
Identification of the genetic causes of inherited retinal dystrophies
Radboudumc - Radboud universitair medisch centrum
Afdeling Oogheelkunde
SPAIN
Aragón
ZARAGOZA
Functional and anatomical preservation of Melatonin and Epigallocatechin Gallate on retinal neurodegenerative models
Hospital Clínico Universitario "Lozano Blesa" de Zaragoza
Servicio de Oftalmología
SPAIN
Cataluña
TERRASSA
Characterization of novel genes associated with Retinosis Pigmentosa (adRP) by whole exome sequencing (WES). Transcritome of retinal derived cells with a PRPF8 mutation
Consorci Sanitari de Terrassa
Unidad de Genética Molecular
SPAIN
Comunidad Valenciana
VALENCIA
Alterations of the intracellular protein degradation mechanisms in Lafora disease, X-linked cerebral adrenoleukodystrophy and retinitis pigmentosa
Centro de Investigación Príncipe Felipe (CIPF)
Laboratorio de Degradación Intracelular de Proteínas y Enfermedades Raras
SPAIN
Comunidad Valenciana
VALENCIA
Application of nanotechnology to the treatment of retinitis pigmentosa with anti-TNFa antibodies. Synergistic effect with antioxidants
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de investigación en biomedicina molecular, celular y genómica
SPAIN
Comunidad Valenciana
VALENCIA
Development of anti-inflammatory nanotherapies for retinitis pigmentosa
IIS La Fe - Instituto de Investigación Sanitaria La Fe
Grupo de investigación en biomedicina molecular, celular y genómica
SPAIN
País Vasco
SAN SEBASTIÁN
Analysis of microRNAs in patients and in murine models of retinitis pigmentosa: novel therapeuthic targets
Instituto de Investigación Sanitaria Biodonostia
Grupo de neurodegeneración sensorial
SWEDEN
Skane
LUND
Retinal transplantation: strategies for clinical therapy of Retinitis pigmentosa
Lund University
Division of Ophthalmology
SWEDEN
Stockholms läns landsting
STOCKHOLM
Genetic and molecular mechanisms in familial visual impairment
Karolinska Institutet - Solna
Department of molecular medicine and surgery
SWITZERLAND
Suisse Italienne
BELLINZONA
Investigating cellular mechanisms regulating protein folding and quality control to intervene in conformational diseases
Istituto di Ricerca in Biomedicina
Protein Folding and Quality Control - Institute for Research in Biomedicine
SWITZERLAND
Suisse Romande
LAUSANNE
AAVEYE: combined therapies to restore vision in Pde6B and Aipl1 murine mutants (WP3)
Hopital Ophtalmique Jules Gonin - Fondation Asile des aveugles
Unit of Gene Therapy & Stem Cell Biology - Hôpital Ophtalmique Jules Gonin
UNITED KINGDOM
Greater London
LONDON
Investigation of the molecular mechanisms between mutations in TOPORS gene and their relation with retinitis pigmentosa
UCL Institute of Ophthalmology
UCL Neuroscience
UNITED KINGDOM
Greater London
LONDON
AAVEYE: gene replacement therapy in Pde6B and Aipl1 murine mutants (WP2)
UCL Institute of Ophthalmology
Molecular Therapy
UNITED KINGDOM
Greater London
LONDON
AAVEYE: molecular and clinical characterization of Retinitis pigmentosa and Leber congenital amaurosis patients with PDE6B and AIPL1 mutations (WP4)
UCL Institute of Ophthalmology
Molecular Therapy
UNITED STATES
California
BERKELEY
Therapeutic approaches for abca4-associated disorders
University Of California Berkeley
Ophthalmology
UNITED STATES
California
BERKELEY
Completing genetic analysis of the abca4 locus
University Of California Berkeley
Ophthalmology
UNITED STATES
California
BERKELEY
Role of impaired protein degradation in photoreceptor degeneration
University Of California Berkeley
Ophthalmology
UNITED STATES
California
BERKELEY
Hdac4-mediated photoreceptor protection in retinal degeneration
University Of California Berkeley
Ophthalmology
UNITED STATES
California
BERKELEY
Evaluation of stem cell-derived retinal pigment epithelial cells for retinal dise
University Of California Berkeley
Ophthalmology
UNITED STATES
California
BERKELEY
Function of ciliary disease protein retinitis pigmentosa gtpase regulator (rpgr)
University Of California Berkeley
Ophthalmology
UNITED STATES
California
BERKELEY
Serotonin receptor modulation of neurotrophic factors in the retina
University Of California Berkeley
Ophthalmology
UNITED STATES
California
BERKELEY
Delaying cone death in retinitis pigmentosa
University Of California Berkeley
Ophthalmology
UNITED STATES
California
BERKELEY
Adaptive optics scanning laser ophthalmoscope-based microperimetry: establishing
University Of California Berkeley
Ophthalmology
UNITED STATES
California
SAN DIEGO
Pharmacological suppression of rod opsin as therapy for retinitis pigmentosa
Orphagen Pharmaceuticals
UNITED STATES
Massachusetts
BOSTON
The pathogenesis of rna splicing factor rp
Massachusetts Eye And Ear Infirmary
UNITED STATES
Missouri
SAINT LOUIS
Endoplasmic reticulum stress in retinal degeneration
Washington University
Pathology
UNITED STATES
Missouri
SAINT LOUIS
Molecular mechanisms of human retinal disease
Washington University
Pathology
UNITED STATES
North Carolina
DURHAM
Coherent light scattering for early detection of retinal disease
Duke University
Biomedical Engineering
UNITED STATES
Ohio
CLEVELAND
Illuminating the process of rod outer segment morphogenesis
Case Western Reserve University
Pharmacology
UNITED STATES
Ohio
CLEVELAND
Pharmacological treatment of retinal diseases
Case Western Reserve University
Pharmacology
UNITED STATES
Ohio
COLUMBUS
In-vivo, high contrast imaging of the human rod photoreceptor mosaic
Ohio State University
None
UNITED STATES
Texas
DALLAS
Unfolded protein response as a therapeutic target for adrp animal models
Ut Southwestern Medical Center
Physiology
UNITED STATES
Texas
HOUSTON
Gene therapy to support cone metabolism in retinitis pigmentosa
Baylor College Of Medicine
Genetics
UNITED STATES
Texas
HOUSTON
Molecular basis of human visual system disorders
Baylor College Of Medicine
Genetics
BELGIUM
OOST-VLAANDEREN
GENT
Cis-regulatory mapping of the RPE-expressed transcription factor OTX2
Center for Medical Genetics Gent
FRANCE
GRAND-EST
STRASBOURG
Retinis Pigmentosa: validation of the molecular diagnostic using next generation sequencing
CHU de Strasbourg - Hôpital Civil
Laboratoire de diagnostic génétique
FRANCE
ILE-DE-FRANCE
PARIS
Comprehensive genetic analysis of inherited retinal disease applying highthroughput next generation sequencing
Institut de la Vision
Département Génétique
FRANCE
ILE-DE-FRANCE
PARIS
Epidemiological study in hereditary dystrophies of retina
Institut de la Vision
Recherche Clinique
FRANCE
OCCITANIE
MONTPELLIER
Gene therapy of retinal dystrophy on human models: differentiation of patients iPS cells to retinal cells
Hôpital Saint Eloi - Bâtiment INM
Equipe "Génétique et thérapie des cécités rétiniennes et du nerf optique"
SPAIN
Andalucía
SEVILLA
Genomic approaches for rare conditions: Inherited Retinal Dystrophies as a model
Hospital Universitario Virgen del Rocío
Unidad de Medicina Maternofetal, Genética y Reproducción
SPAIN
Cataluña
BARCELONA
Design of a genetic diagnostic chip for retinal dystrophies
Universitat de Barcelona. Facultat de Biologia
Departamento de Genética
UNITED KINGDOM
Cambridgeshire
CAMBRIDGE
Active BRIDGE Studies - Specialist Pathology: Evaluating Exomes in Diagnostics (SPEED)
Wellcome Trust/MRC Building
Cambridge Institute for Medical Research
GERMANY
Hessen
GIEßEN
Diagnosis and therapy of hereditary retinal diseases
Augenklinik des UKGM am Standort Gießen
Klinik und Poliklinik für Augenheilkunde
SPAIN
Madrid
MADRID
An integrated analysis system to increase the rate of diagnosis of rare diseases using massive sequencing
Fundación Jiménez Díaz
Área de Genética y Genómica
ITALY
CAMPANIA
NAPOLI
Telethon Undiagnosed Disease Program - Revised Proposal
Azienda Ospedaliera Universitaria - Seconda Università degli Studi di Napoli
Laboratorio di Genetica Medica
Multicentric Research projects
- Centre hospitalier national d'ophtalmologie des Quinze-Vingts
- Centre de Référence REFERET
- Institut de la Vision
- Recherche Clinique
- Université Pierre et Marie Curie - Paris 6
- Département Traitement des Informations Visuelles
- Department für Augenheilkunde Tübingen
- Molekulargenetisches Labor
- Department für Augenheilkunde Tübingen
- Forschungsinstitut für Augenheilkunde
- TIGEM - Telethon Institute of Genetics and Medicine
- Laboratorio di Ricerca
- Institut de la Vision
- Recherche Clinique
- Fundación Jiménez Díaz
- Servicio de Genética Clínica
- Department für Augenheilkunde Tübingen
- Forschungsinstitut für Augenheilkunde
- Radboudumc - Radboud universitair medisch centrum
- Afdeling Genetica
- EEIG - EUROPEAN VISION INSTITUTE
- EUROPEAN VISION INSTITUTE
- University of British Columbia
- Maternal Infant Child and Youth Research Network
- IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO
- Servizio Clinico di Consulenza Genetica
FRANCE
ILE-DE-FRANCE
PARIS
RHORCOD: comprehensive analysis of rod-cone photoreceptor degeneration associated with Rhodopsin gene mutations
FRANCE
ILE-DE-FRANCE
PARIS
RDCVF: rod-derived cone viability factor (TERMINATED)
FRANCE
ILE-DE-FRANCE
PARIS
OPTOREMODE: Retinitis Pigmentosa diagnosis and therapy: retinal remodeling and optogenetic reactivation of degenerated retina
GERMANY
Baden-Württemberg
TÜBINGEN
RETNET: European Retinal Research Training Network
GERMANY
Baden-Württemberg
TÜBINGEN
DRUGSFORD: Preclinical development of drugs and drug delivery technology for the treatment of inherited photoreceptor degeneration
ITALY
CAMPANIA
NAPOLI
AAVEYE: gene therapy for inherited severe photoreceptor diseases
FRANCE
ILE-DE-FRANCE
PARIS
EVI-GENORET: functional genomics of the retina in health and disease (FINISHED)
SPAIN
Madrid
MADRID
EsRetNet: Spanish Network of Reseach on Retinal Dystrophies
GERMANY
Baden-Württemberg
TÜBINGEN
HOPE 2: Hereditary Retinal Disorders - From Patients Towards Therapies
NETHERLANDS
Gelderland
NIJMEGEN
SYSCILIA: A systems biology approach to dissect cilia function and its disruption in human genetic disease
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUXELLES
EuroVisionNet: Slechtziendheid en Degeneratie: Een draaiboek voor onderzoek naar gezichtsvermogen in Europe (AFGEROND)
CANADA
Colombie-Britannique
VANCOUVER
Maternal Infant Child and Youth Research Network (MICYRN)
ITALY
LAZIO
ROMA